logo
Select company
Select metric
-8380.25%Free Cash Flow Margin
VS
Market
2
Sector
6
Industry
11
History
-
$ 0.37Close
$ 0.29 - $ 4.28 52-Week Range
Ticker Information

Ticker

VYNE

Company Name

VYNE THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

VYNE THERAPEUTICS INC - Free Cash Flow Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

VYNE - FCF % Historical data
DateFree Cash FlowFree Cash Flow MarginRevenues
6/30/2025$ -39.89M-8380.25%$ 476K
3/31/2025$ -37.57M-6209.59%$ 605K
12/31/2024$ -34.09M-6804.19%$ 501K
9/30/2024$ -30.11M-6107.51%$ 493K
6/30/2024$ -26.75M-5504.53%$ 486K
3/31/2024$ -27.84M-6582.74%$ 423K
12/31/2023$ -25.34M-5976.65%$ 424K
9/30/2023$ -24.08M-6801.98%$ 354K
6/30/2023$ -26.05M-6400.98%$ 407K
3/31/2023$ -24.7M-6206.78%$ 398K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • VYNE THERAPEUTICS INC's latest trailing twelve months (TTM) FCF % stands at -767.55%.
  • Over the past 5 years, VYNE THERAPEUTICS INC's average FCF % has been -3834.76%.
  • The median FCF % for VYNE THERAPEUTICS INC during this period was -5740.59%
  • VYNE THERAPEUTICS INC reached its highest FCF % over the past 5 years at -382.02%.
  • The lowest FCF % recorded by VYNE THERAPEUTICS INC in the same timeframe -8380.25%

VYNE THERAPEUTICS INC's FCF % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

FCF % Benchmarks
CompanyFCF %
ERNA : ERNEXA THERAPEUTICS INC -2960.25%BRTX : BIORESTORATIVE THERAPIES INC -1590.77%HCWB : HCW BIOLOGICS INC -7629.26%LYRA : LYRA THERAPEUTICS INC -5584.68%APRE : APREA THERAPEUTICS INC -1514.98%AIM : AIM IMMUNOTECH INC -9304.13%IBIO : IBIO INC -3830%ADIL : ADIAL PHARMACEUTICALS INC -CELZ : CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC -94756.77%DWTX : DOGWOOD THERAPEUTICS INC -

Definition of Free Cash Flow Margin

[Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
FCF / Revenues
(=) FCF %
FCF % for VYNE THERAPEUTICS INC is calculated as follows: FCF [ $ -128.23M ] / Revenues [ $ 16.71M ]
(=) FCF % [ -767.55% ]

VYNE - Free Cash Flow Margin, Last 5 years

-8380.25%

Minimum

Jun 30, 2025

-382.02%

Maximum

Dec 31, 2021

-3834.76%

Average

-5740.59%

Median

FCF % Benchmark Analysis

The chart above depicts the distribution of FCF % for companies in the Total Stock Market. The average FCF % of the companies is 7.87% with a standard deviation of 19.48%.
The following table provides additional summary stats:
FCF % in the Market:
filtered constituents3.18K
min-58.23%
max68.19%
average7.87%
median7.4%
std19.48%